logo-loader
G Medical Innovations Holdings Ltd

G Medical Innovations delivers revenue growth; secures first US commercial order

The company is making solid progress with its medical devices, having signed its first US commercial order in January 2019.

Prizma smart-phone case
Prizma smart-phone case

G Medical Innovations Holdings Ltd (ASX:GMV) has achieved a total revenue of US$3.06 million for the year ended December 31, 2018, representing an increase of US$2.95 million compared to 2017.

The increase is primarily attributable to CardioStaff's and Telerhythmics's sales of services in the US.

G Medical’s acquisition of Telerhythmics in 2018, along with its acquisition of Cardiostaff Diagnostic Services Inc in 2017, has created a sizable player in the US cardiac diagnostic monitoring space.

READ: G Medical Innovations secures first US commercial orders valued at almost US$22 million

The company is also making solid progress with its medical devices, having signed its first US commercial orders in January 2019 valued at almost US$22 million for the Prizma Medical smart-phone case and Vital Signs Monitoring System.

G Medical aims to reduce inefficiencies in healthcare delivery with products such as the Prizma smart-phone case, which transforms any smart-phone into a medical monitoring device.

READ: G Medical Innovations Holdings Ltd on track for revenue growth in 2019

The purchaser is diversified US healthcare company Hygea and two subsidiaries specialising in many aspects of healthcare from insurance, finance, medicine and technology.

The orders are for a 24-month term beginning on April 1, 2019, with payments scheduled on a monthly basis of amounts varying between US$90,000 and US$1.33 million.

G Medical will provide the Prizma smart-phone cases and Vital Signs Monitoring System, also known as G Medical Patch (GMP), to Hygea clinics and practices as well as to the subsidiaries.

Quick facts: G Medical Innovations Holdings Ltd

Price: $0.13

Market: ASX
Market Cap: $51.9 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of G Medical Innovations Holdings Ltd named herein, including the promotion by the Company of G Medical Innovations Holdings Ltd in any Content on...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian e-health company G Medical Innovations eyes Nasdaq listing

G Medical Innovations Holdings Ltd (ASX:GMV) CEO Yacov Geva sits down with Proactive Investors' Christine Corrado in New York to update investors on the mobile and e-health company's move to list on the Nasdaq. Geva says the company, which specializes in software and devices that aim to...

on 10/15/2018

2 min read